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(61%) underwent muscle flap cover of the FPV reconstruction. In-hospital/
30-day mortality was 5.4% (2 of 37); one from respiratory failure 20 days
postoperatively, and the second, a 93-year-old woman, after withdrawal of
care at 24 hours. No patients required fasciotomy, and five wound hemato-
mas required reoperation. Focal femoropopliteal vein thrombosis occurred
in five limbs. Over a mean follow-up of 2.5 years (range, 0.03-13.3) 11
patients died of unrelated causes at a mean of 3.7 years (range, 0.2-10.6
years). Graft reintervention was required in seven patients during follow-up
for graft thromboses (n  2) stenoses (n  2), and anastomotic false
aneurysms (n  3). Apart from the latter, there was no other suggestion of
graft reinfection in any patient. Major limb loss occurred in one patient at 6
months despite a patent graft. Long-term FPV harvest morbidity included
mild leg swelling in 10 patients.
Conclusions: Replacement of infected synthetic grafts/femoral arter-
ies in the groin with FPV is safe and results in excellent limb preservation and
freedom from reinfection. FPV should be considered the preferred conduit
in good-risk patients with infection limited to the groin.
Secondary Interventions After Elective Thoracic Endovascular Aortic
Repair (TEVAR) for Degenerative Aneurysms: Incidence and
Outcomes
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Objectives: We assessed the incidence and outcomes of secondary
interventions (SI) after elective thoracic endovascular aortic repair (TEVAR)
for aneurysmal disease.
Methods:An institutional review of TEVAR performed for descending
thoracic aneurysms (DTAA) between 2000 and 2011 was performed from a
prospectively maintained database. Only elective cases of TEVAR for DTAA
using commercially available endografts were selected. The incidence of
unplanned graft-related SI (ie, open conversion or proximal or distal exten-
sions) was examined. Outcomes of each SI were then analyzed.
Results:We identified 83 patients who underwent elective TEVAR for
DTAA. Eight patients (9.52%) subsequently required graft-related SIs. The
mean interval to SI was 31.8 months. Patients who required SI were
significantly younger than patients who did not require SI (mean age,
57.5 11.6 vs 69.3 11.4 years, P .05). Endoleak was themost common
indication for SI: five patients (62.5%) underwent SI for a type I endoleak (4
type IA, 1 type IB), one for aneurysmal progression without endoleak, one
for type II endoleak, and 1 for type III endoleak. In the SI group, two
patients (25%) required open conversion, five (62.5%) required secondary
TEVAR (3 proximal and 1 distal extensions, and 1 relining), and 1 required
endovascular coiling only. In the SI group, clinically relevant perioperative
events occurred in three patients with one stroke (12.5%) and two access
complications (25%). Operative mortality (30 day) was zero with one
aneurysm-related late death occurring at 2 years after SI. Factors that
predispose the need for SI were fusiform morphology of the aneurysm (P
.05) and extent of graft coverage in the proximal landing zone (P  .05).
Size of the aneurysm treated and the type of device used were not significant
factors leading to SI.
Conclusions: Short-term and midterm results of elective TEVAR for
DTAA demonstrate good durability with acceptable rates of graft-related SI.
All currently available commercial endografts seem to perform equally in this
setting. Age, fusiform aneurysm morphology, and extent of proximal land-
ing zones were significant factors that led to subsequent SI. When SI is
necessary, most issues can be resolved via endovascular means. Conversion
to open repair, however, is not insignificant and may lead to increased
operative morbidity.
Rate of Malignancy Detected on Postendovascular Aneurysm Repair
Surveillance Computed Tomography Angiogram
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Objectives: Intuitively, patients with aortic aneurysms represent a
high-risk population for the development of a variety of tumors. We sought
to identify the incidence and pattern of new cancer diagnoses in a cohort
after endovascular aneurysm repair (EVAR), and to determine the rate with
which these diagnoses were obtained by surveillance computed tomography
angiogram (CTA).
Methods: A prospective cohort of 331 patients undergoing endovas-
cular exclusion of 286 abdominal aortic aneurysms, 31 thoracoabdominal
and descending thoracic aortic aneurysms, and 14 isolated common iliac
artery aneurysms between 1997 and 2009 was analyzed. We identified all
patients diagnosed with new thoracic and abdominal tumors in addition to
leukemia and lymphoma.
Results: Of this cohort, 193 patients (58%) carried a preoperative
history of malignancy. The most common tumors encountered included
prostate (n  28), lung (n  14), and breast (n  10). During a median
follow-up of 37 months, 29 patients (8.7%) developed 31 tumors. Thirteen
of these tumors (45%) included newly diagnosed lung cancers in addition to
renal cell carcinoma (n  3), colon cancer (n  2), prostate cancer (n  2),
and lymphoma (n  2). Sixteen of these tumors (55%) were identified on
post-EVAR surveillance CTA. The most common tumor encountered on
post-EVAR surveillance CT was lung cancer (n  7), 80% of which were
stage I or “limited” at the time of diagnosis; all renal cell carcinomas (n 3)
were identified in this fashion. Mean interval to diagnosis after EVAR was
31.3 months.
Conclusions: Compared with the general population, patients with
aortic aneurysms carry a heightened risk of cancer development. Serial CT
scans for post-EVAR surveillance may reveal a high rate of malignancy in this
population, such that vascular surgeons should remain observant and pre-
pared to arrange for the appropriate oncologic follow-up. It seems possible
that post-EVAR surveillance may allow for earlier cancer detection, and an
effort to further identify whether this early detection offers a clinical or
survival benefit is warranted.
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Lynch, MD, and Iraklis I. Pipinos, MD. Creighton University and Depart-
ment of Surgery, Creighton University; and University of Nebraska Medical
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Objectives: Published literature on postoperative outcomes after aortic
surgery for prosthetic aortic graft infection (AGI) is limited by relatively
small sample sizes resulting in lack of national benchmarks for quality of care.
We report in-hospital outcomes after aortic surgery for AGI and identify
factors associated with postoperative complications using the Nationwide
Inpatient Sample (NIS) database.
Methods: Patients who underwent aortic graft resection for AGI were
identified from the 2002 to 2008 NIS database, a multicenter database
capturing 20% of all United States admissions. Multivariable logistic regres-
sion analyses were performed.
Results: In 394 patients (73.4% men) who underwent aortic surgery
for AGI, median age was 72 years. Fifty-three percent of the admissions were
emergent or urgent. Median hospital volume of aortic surgery for AGI
during the study period was one case. A significant trend for decreasing
number of AGIs per year was observed during the study span (Pearson’s
correlation r	0.96; P .0006). During the same time span, a significant
correlation was also seen with decrease in open, and increase in endovascular
aortic aneurysm repairs in the NIS database (Fig). In-hospital rates of overall
postoperative morbidity and mortality were 68.3% and 19.8%, respectively.
In-hospital rates of postoperative respiratory failure, renal failure, and cardiac
arrest were 35.5%, 14.2%, and 8.9%, respectively. Median length of stay was
26 days, with median hospital charges being $184,162. On multivariable
analysis, increase in age per year (odds ratio, 1.07; 95% confidence interval,
1.03-1.12) was independently associated with postoperative morbidity,
whereas higher hospital volume for this procedure was protective (odds
ratio, 0.71; 95% confidence interval, 0.56-0.89). On multivariable analysis,
Fig.
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no preoperative factors were independently associated with postoperative
mortality.
Conclusions: AGI incidence has progressively declined during the
span of our study in association with decreased open and increased endovas-
cular aortic aneurysm repairs. Aortic surgery for AGI is associated with very
highmorbidity andmortality rates, along with prolonged lengths of stay and
elevated hospital charges. The outcomes of operations for AGI are better in
younger patients and higher volume hospitals.
In-Hospital and Postdischarge Venous Thromboembolism After Vas-
cular Surgery
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Objectives:Recent single-center reports demonstrate high (up to 10%)
incidence of postoperative venous thromboembolism (VTE) after major
vascular surgery. Moreover, vascular patients rarely receive prolonged pro-
phylaxis, despite evidence that it reduces postdischarge events. The objective
of our study was to use a national, prospective, multicenter database to (1)
define the frequency of overall and postdischarge VTE after major vascular
operations and (2) assess risk factors associated with VTE development.
Methods: Patients who experienced a VTE after elective vascular
procedures (n  45,548) were identified from 2007 to 2009 National
Surgical Quality Improvement Program database. The vascular procedures
included carotid endarterectomy (CEA; n 20,785), open thoracoabdomi-
nal aneurysm (TAAA) repair (n  361), thoracic endovascular aortic repair
(TEVAR; n  732), open abdominal aortic aneurysm (AAA) repair (n 
6195), endovascular aneurysm repair (EVAR; n  7361), and infrainguinal
bypass graft (BPG; n  10,114).
Results: VTE was diagnosed in 332 patients (0.7%), consisting of
pulmonary embolism (PE) in 0.2% and deep venous thrombosis (DVT) in
0.6%. TAAA repair had the highest rate of VTE (4.2%), followed by TEVAR
(2.2%), open AAA repair (1.7%), BPG (1.0%), EVAR (0.7%), and CEA
(0.2%) (P  .0001). Forty-one percent of these VTEs were diagnosed after
discharge. The number of days (mean standard deviation) from operation
to DVT and PE were 11.12 7.76 and 11.40 8.56 days, respectively. On
multivariate analyses, type of surgical procedure, totally dependent func-
tional status, disseminated cancer, postoperative organ space infection,
postoperative cerebrovascular accident, failure to wean from ventilator48
hours and return to the operating room were significantly associated with
development of VTE (Table). In those experiencing a DVT or PE, overall
mortality increased from 1.5% to 6.2% and from 1.5% to 5.7%, respectively
(P  .05 for both).
Conclusions: Postoperative VTE is associated with type of vascular
procedure and is highest after operations in the chest and abdomen/pelvis.
About 40% of VTE events in elective vascular surgery patients were diag-
nosed after discharge. Future studies should evaluate the benefit of DVT
screening or postdischarge VTE prophylaxis in high-risk patients.
Table. Multivariate analyses of venous thromboembolism
Parameter OR 95% CI
Procedurea
TAAA 3.71 1.12-12.26
TEVAR 4.96 1.94-12.69
Open AAA 4.23 2.23-7.99
Infrainguinal bypass graft 3.33 1.67-6.63
EVAR 2.82 1.46-5.47
Totally dependent functional status 1.96 1.18-3.28
Postoperative CVA 2.58 1.14-5.81
Disseminated cancer 16.39 3.10-83.33
Organ space infection 3.25 1.10-9.61
Failure to wean 4.18 2.18-8.06
Return to operating room 2.09 1.34-3.27
AAA, Abdominal aneurysm repair; CI, confidence interval; CVA, cerebro-
vascular accident; EVAR endovascular aneurysm repair; OR, odds ratio;
TAAA, thoracoabdominal aneurysm repair; TEVAR, thoracic endovascular
aortic repair.
aReference category for procedure: carotid endarterectomy.
Effectiveness of Isolated Pectoralis Minor Tenotomy (PMT) in Se-
lected Patients With Neurogenic Thoracic Outlet Syndrome (NTOS)
Chandu Vemuri, MD, AnnaM.Wittenberg, Francis J. Caputo, MD, Valerie
B. Emery, RN, and Robert W. Thompson, MD. Department of Surgery,
Washington University in Saint Louis, St. Louis, Mo.
Objectives: Pectoralis minor tenotomy (PMT) is a potential surgical
option for selected patients with neurogenic thoracic outlet syndrome
(NTOS. The purpose of this study was to evaluate the effectiveness of
isolated PMT as compared with supraclavicular decompression (SCD: sca-
lenectomy, neurolysis, and first rib resection) first.
Methods: Data were obtained for 200 patients undergoing opera-
tive treatment for disabling NTOS between 2008 and 2011. Patients
with physical examination findings limited to the subcoracoid space were
offered isolated PMT (n  57), whereas those with scalene triangle
findings were offered SCD first (n  143). Functional outcomes were
assessed using the Disabilities of the Arm, Shoulder and Hand (DASH)
survey instrument.
Results: There were no significant differences (P .05) between PMT
and SCD patients with respect to age (37.1 0.9 years), sex (73.0% female),
side affected (52.0% right, 14.5% bilateral), presence of depression (36.0%),
history of injury (53.5%), or the nature, duration, and magnitude of symp-
toms. Diagnostic muscle blocks were positive in 27 of 34 PMT (79.4%)
patients. Mean preoperative DASH scores were similar between PMT and
SCD groups (49.9  3.6 vs 50.8  1.6), but previous use of opiate pain
medications was higher in PMT patients (45.6% vs 20.3%, P  .0004). All
PMTs were conducted as outpatient procedures, whereas mean hospital stay
after SCD was 4.8  0.1 days. Mean DASH scores at 3 months were
significantly improved after PMT (29.6 4.2, P .0005) and SCD (39.3
2.3, P  .0001), but the extent of improvement in DASH scores was not
significantly different between groups (32.1%  9.4% vs 23.9%  4.7%).
There were also no significant differences in the proportion of patients
demonstrating functional improvement (75.0% vs 73.3%) or use of opiate
medications (35.1% vs 27.3%).
Conclusions: Isolated PMT was effective treatment for NTOS in
properly selected patients, demonstrating clinical and functional outcomes
similar to conventional SCD. These findings support an important role for
PMT in the management of NTOS.
Clinical Presentation, Age, and Comorbidities but not Female Gender
Predict Survival After Endovascular Repair of Abdominal Aortic An-
eurysm (EVAR)
Peter Gloviczki, MD, Gustavo S. Oderich, MD, Audra A. Duncan, MD, Manju
Kalra, MD, William S. Harmsen, Patrick D. Fitz-Gibbon, Catherine E. Dvorak,
RN,LindaG.Canton,RN, andThomasC.Bower,MD. Division ofVascular and
Endovascular Surgery, Mayo Clinic, Rochester, Minn
Objectives: This study examined associations between age, gender,
clinical factors, and outcome after EVAR.
Methods: Data on patients who underwent EVAR between 1997 and
2011 at our institution have been analyzed. SVS comorbidity scores were
used to stratify patients into good risk (score 10) or high-risk category
(score 10). End points were early and late mortality, morbidity, reinter-
ventions, ruptures, and survival. Questionnaires were mailed to update
follow-up information. The Kaplan-Meier method was used to estimate
survivals. Associations with outcomes were assessed with 2 test or Cox
proportional hazards regression.
Results: The study comprised 1008 consecutive patients (133
women, 875 men), who were a mean age of 76 years (range, 49-99
years). Technical success was 96%, including 99% for elective EVAR,
100% for symptomatic abdominal aortic aneurysms (AAA), and 95% for
ruptured AAA (RAAA; P  .001) In-hospital mortality was 1.6% (16 of
1008); elective EVAR: 1% (9 of 922), symptomatic AAA: 4.5% (2 of 44),
and RAAA: 11.9% (5 of 42; P  .001). Thirty-day elective mortality was
2.2% (8 of 369) in high-risk patients, and 0.2% (1 of 552) in good-risk
patients (P  .003). Follow-up averaged 3.4 years (range, 1 month-13.5
years). Clinical presentation (elective vs symptomatic or ruptured) was
associated with 5-year survival of 64.08% vs 56.08% or 57.42%. After
elective EVAR, 5-year survival was 72% for good-risk and 51% for
high-risk patients (P  .001); both had similar freedom from complica-
tions (75% vs 75%, P  .56), reinterventions (75% vs 78%, P  .76), or
rupture (99% vs 100%, P  .73). Age and high surgical risk were
associated with complications (P  .03) and early and all-cause late
mortality (P .001). Female gender was not associated with a significant
increase in mortality, although it was associated with complications
(Table).
Conclusions:EVAR can be performedwith a low rate of complications
and mortality, even in high-risk patients or in those with symptoms or
rupture. Urgent presentation, age over 80 years and high co-morbidity
scores are associated with complications and higher mortality. Although
female sex is associated with complications, women did not have a signifi-
cantly higher mortality than men.
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